Research Topics
| D W LosordoSummaryAffiliation: Tufts University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Estrogen and angiogenesis: A reviewD W Losordo
Divisions of Cardiovascular Medicine and Research, St Elizabeth s Medical Center, Boston, Massachusetts, USA
Arterioscler Thromb Vasc Biol 21:6-12. 2001..Despite these consistent observations, the mechanisms by which estrogen regulates angiogenesis under physiological and pathological circumstances have not been defined...
Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectorisD D Esakof
Department of Medicine, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
Hum Gene Ther 10:2307-14. 1999..We conclude that MPTEE is a useful tool for ensuring that myocardial gene therapy performed by direct needle injection results in gene transfer to the LV myocardium...
Gene therapy with vascular endothelial growth factor for inoperable coronary artery diseaseJ F Symes
Department of Surgery, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
Ann Thorac Surg 68:830-6; discussion 836-7. 1999..We initiated a phase I clinical trial to assess the safety and bioactivity of intramyocardial transfection of plasmid DNA encoding for the angiogenic mitogen vascular endothelial growth factor (ph-VEGF165) in such patients...
Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and resultsK G Lathi
Department of Anesthesiology, St Elizabeth s Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
Anesth Analg 92:19-25. 2001..Our study describes the anesthetic considerations and management of such patients treated with a novel approach by using gene therapy to stimulate angiogenesis and improve perfusion to ischemic myocardium...
Assessment of risks associated with cardiovascular gene therapy in human subjectsJ M Isner
Shaughnessy Center for Clinical Genetics, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02493, USA
Circ Res 89:389-400. 2001....
Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemiaP R Vale
Departments of Medicine, Cardiovascular Research, Cardiothoracic Surgery, St Elizabeth s Medical Center, Tufts Medical School, Boston, Massachusetts, USA
Circulation 103:2138-43. 2001..Conclusions-This randomized trial of catheter-based phVEGF-2 myocardial GTx provides preliminary indications regarding the feasibility, safety, and potential efficacy of percutaneous myocardial GTx to human left ventricular myocardium...
[Growth factors for therapeutic angiogenesis in cardiovascular diseases]P R Vale
, St. Elizabeth's Medical Center, Tuft's University School of Medicine, Boston, Massachusetts, USA
Rev Esp Cardiol 54:1210-24. 2001..Nevertheless, it seems clear that it is feasible to induce effective therapeutic angiogenesis in selected patients without significant associated toxicity...
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MISatoshi Shintani
Division of Cardiovascular Research, Caritas St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
Nat Clin Pract Cardiovasc Med 3:S123-8. 2006..This approach may overcome therapeutic failures (e.g. inability of certain patients to mobilize sufficient EPCs) and may also offer safety advantages by allowing lower dosing strategies...
Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix mAtsushi Iwakura
Division of Cardiovascular Research, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA, USA
Circulation 113:1605-14. 2006..We hypothesized that estradiol could augment the incorporation of bone marrow (BM)-derived EPCs into sites of ischemia-induced neovascularization, resulting in protection from ischemic injury...
Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodelingJun Asai
Division of Cardiovascular Research and Medicine, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA, USA
Circulation 113:2413-24. 2006..Because diabetes is associated with impaired wound healing, we tested this hypothesis in a diabetic model of cutaneous wound repair...
Netrins promote developmental and therapeutic angiogenesisBrent D Wilson
Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake City, UT 84112, USA
Science 313:640-4. 2006..We propose that the attractive vascular and neural guidance functions of netrins offer a unique therapeutic potential...
Statins and the endotheliumMasaaki Ii
Stem Cell Translational Research, RIKEN Center for Developmental Biology, 2 2 Minatojima, Minamimachi, Kobe, Japan
Vascul Pharmacol 46:1-9. 2007..This review provides an update of the unique effects of statins on endothelial cells including endothelial progenitor cells as well as highlighting the therapeutic potential of statins beyond their established lipid-lowering effects...
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expressionJohnson Rajasingh
Division of Cardiovascular Research, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
FASEB J 20:2112-4. 2006....
Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injuryMasaaki Ii
Division of Cardiovascular Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
Circ Res 98:697-704. 2006....
Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signalingKengo F Kusano
Division of Cardiovascular Research, St Elizabeth Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
Nat Med 11:1197-204. 2005....
Non-viral vectors for gene therapy: clinical trials in cardiovascular diseasePinak B Shah
Division of Cardiology, Caritas St. Elizabeth's Medical Center Boston, Massachusetts 02135, USA
Adv Genet 54:339-61. 2005..This chapter will describe the clinical trial experience to date with delivery of non-viral gene therapy for therapeutic angiogenesis in humans with disabling myocardial ischemia and peripheral vascular disease...
Ethanol modulation of TNF-alpha biosynthesis and signaling in endothelial cells: synergistic augmentation of TNF-alpha mediated endothelial cell dysfunctions by chronic ethanolCorinne Luedemann
Division of Cardiovascular Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
Alcohol Clin Exp Res 29:930-8. 2005..Taken together, these data indicate that chronic ethanol consumption may negatively influence post angioplasty re-endothelialization thereby contributing to the development of restenosis...
Repair of ischemic heart disease with novel bone marrow-derived multipotent stem cellsNamho Lee
Division of Cardiovascular Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
Cell Cycle 4:861-4. 2005..In this review, we will discuss the currently available bone marrow-derived stem progenitor cells for myocardial repair and focus on the advantages of using recently identified novel bone marrow-derived multipotent stem cells (BMSC)...
The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin ARaj Kishore
Division of Cardiovascular Research, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
J Clin Invest 115:1785-96. 2005....
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemiaMarta Bosch-Marce
Department of Medicine Cardiovascular Research, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135 2997, USA
Vasc Med 10:15-22. 2005..In contrast, our data suggest that impaired Akt phosphorylation mediates the impairment of angiogenesis associated with HH...
Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of Young Sup Yoon
Division of Cardiovascular Research, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 111:2073-85. 2005..Diabetic cardiomyopathy (DCM) is characterized by microvascular pathology and interstitial fibrosis, which leads to progressive heart failure; however, the pathogenesis of DCM remains uncertain...
CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cellsAtsuhiko Kawamoto
Division of Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 114:2163-9. 2006..4+/-0.4, 24.9+/-0.4, and 24.1+/-0.6; P<0.05). CONCLUSIONS: CD34+ cells exhibit superior efficacy for preserving myocardial integrity and function after MI than unselected circulating MNCs...
Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarctionHiromichi Hamada
Division of Cardiovascular Research, St Elizabeth Medical Center of Boston, Tufts University School of Medicine, Boston, Mass, USA
Circulation 114:2261-70. 2006..However, the roles of estrogen receptors alpha (ER alpha) and beta (ER beta) in EPC biology are largely unknown...
Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of ageJörn Tongers
Circulation 118:9-16. 2008
Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repairJohnson Rajasingh
Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave, Chicago IL 60611, USA
Circ Res 102:e107-17. 2008..These data provide evidence for the generation of functional multipotent stem-like cells from terminally differentiated somatic cells without the introduction of retroviral mediated transgenes or ESC fusion...
Endothelial progenitor cells for cardiovascular regenerationAtsuhiko Kawamoto
Vascular Regeneration Research Group, Institute of Biomedical Research and Innovation, Kobe, Japan
Trends Cardiovasc Med 18:33-7. 2008..This review summarizes the progression of basic, preclinical, and clinical research into the potential use of EPC therapy for cardiovascular regeneration...
Therapeutic myocardial angiogenesisMarie Ange Renault
Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Tarry 12 703, Chicago, IL 60611, USA
Microvasc Res 74:159-71. 2007....
STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarctionJohnson Rajasingh
Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave, Chicago, IL 60611, USA
Circ Res 101:910-8. 2007..Thus augmentation of LIF/BMP-2 downstream signaling components or cell type specific precommitment may facilitate the effects of ES cell-based therapies for post-MI myocardial repair and regeneration...
Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycleSamar Farha
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA
J Appl Physiol 103:1789-95. 2007..These findings suggest that angiogenesis in the lungs may participate in the cyclic changes in gas transfer that occur over the menstrual cycle...
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trialDouglas W Losordo
Feinberg Cardiovascular Research Institute, and Department of Medicine, Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital, Chicago, IL 60611, USA
Circulation 115:3165-72. 2007..Preclinical studies have indicated that human CD34+ stem cells induce neovascularization in ischemic myocardium, which enhances perfusion and function...
Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cellsMargot Egger
Department of Internal Medicine, University of Innsbruck, Anichstr 35, 6020 Innsbruck, Austria
FASEB J 21:2906-17. 2007..In summary, our data show that the angiogenic cytokine secretoneurin is up-regulated by hypoxia in muscle cells by hypoxia-inducible factor-1alpha- and basic fibroblast growth factor-dependent mechanisms...
The matrix revolutions: matrix metalloproteinase, vasculogenesis, and ischemic tissue repairMarie-Ange Renault
Circ Res 100:749-50. 2007
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healingKazuichi Maruyama
Schepens Eye Research Institute, 20 Staniford Street, Boston, MA 02114, USA
Am J Pathol 170:1178-91. 2007..These observations suggest a potential therapeutic approach for healing wounds in diabetic patients...
Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularizationDavid A Goukassian
Division of Cardiovascular Diseases, Department of Medicine, Caritas St Elizabeth s Medical Center, Boston, Mass, USA
Circulation 115:752-62. 2007..Little is known about the role of TNF-alpha receptors (TNFR1/p55 and TNFR2/p75) in angiogenic signaling...
Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarctionKengo Kusano
Cardiovascular Research, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge St, Boston, MA 02135, USA
J Mol Cell Cardiol 42:390-9. 2007....
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGFRudolf Kirchmair
Department of Cardiovascular Research, St Elizabeth s Medical Center Tufts University School of Medicine, Boston, Massachusetts, USA
Mol Ther 15:69-75. 2007..These findings implicate microvascular damage as the basis for toxic neuropathy and suggest that angiogenic growth factors may constitute a novel treatment for this disorder...
Critical role of endothelial Notch1 signaling in postnatal angiogenesisKyosuke Takeshita
Vascular Medicine Research Unit, Brigham and Women s Hospital, Boston, MA, USA
Circ Res 100:70-8. 2007..These results suggest that Notch1 may be a novel therapeutic target for improving angiogenic response and blood flow recovery in ischemic limbs...
Use of recombinant adeno-associated viral vectors as a tool for labeling bone marrow cellsAtsushi Iwakura
Cardiovascular Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, MA 02135, USA
J Mol Cell Cardiol 38:799-802. 2005..rAAV vectors programmed stable transduction in BM cells in vivo through rapid infection. rAAV appears to represent a useful vector for labeling BM cells ex vivo prior to BMT for analysis of cardiovascular therapeutic purposes...
Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activityMasaaki Ii
Division of Cardiovascular Research, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 111:1114-20. 2005..The possibility that EPCs could act as reservoirs of cytokines has been implied by several observations; however, a specific role for cytokine delivery has not been identified...
Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growthDavid A Goukassian
Department of Medicine, Division of Cardiovascular Research, St Elizabeth's Medical Center, Boston, Mass, USA
Circ Res 93:162-9. 2003....
Endothelial recovery: the next target in restenosis preventionDouglas W Losordo
Circulation 107:2635-7. 2003
Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemiaPeter Schratzberger
Department of Internal Medicine, Division of General Internal Medicine, University Hospital Innsbruck, Innsbruck, Austria
Curr Pharm Des 9:1041-7. 2003..This review will discuss gene transfer strategies for therapeutic angiogenesis in critical limb and myocardial ischemia...
Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularizationJun-ichi Yamaguchi
Division of Cardiovascular Research and Medicine, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 107:1322-8. 2003..0001). CONCLUSION: These findings indicate that locally delivered SDF-1 augments vasculogenesis and subsequently contributes to ischemic neovascularization in vivo by augmenting EPC recruitment in ischemic tissues...
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedemaYoung Sup Yoon
Department of Vascular Medicine, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
J Clin Invest 111:717-25. 2003..This novel therapeutic strategy may merit clinical investigation in patients with lymphedema...
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemiaAtsuhiko Kawamoto
Division of Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 107:461-8. 2003..CONCLUSIONS: These favorable outcomes encourage future clinical trials of catheter-based, intramyocardial transplantation of autologous CD34+ MNCs in the setting of chronic myocardial ischemia...
Biological revascularization and the interventional molecular cardiologist: bypass for the next generationDouglas W Losordo
Circulation 106:3002-5. 2002
Transcutaneous ultrasound augments naked DNA transfection of skeletal musclePeter Schratzberger
Department of Cardiovascular Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
Mol Ther 6:576-83. 2002..The biological significance of this finding was confirmed by augmented limb perfusion in response to US exposure and naked VEGF DNA...
Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cellsSatoshi Murasawa
Department of Medicine (Vascular Medicine, Cardiology, Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 106:1133-9. 2002..This enhanced regenerative activity of EPCs by hTERT transfer will provide novel therapeutical strategy for postnatal neovascularization in severe ischemic disease patients...
Functionally novel tumor necrosis factor-alpha-modulated CHR-binding protein mediates cyclin A transcriptional repression in vascular endothelial cellsRaj Kishore
Division of Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circ Res 91:307-14. 2002..Additionally, exposure of ECs to TNF-alpha markedly reduced cyclin A mRNA stability. Targeted disruption of this protein could potentially be a therapeutic strategy to rescue EC proliferation in vivo...
Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivoToshinori Murayama
Division of Cardiovascular Research, Department of Medicine, St. Elizabeth's Medical Center of Boston, Tufts University School of Medicine, Brighton, Mass 02135-2997, USA
Exp Hematol 30:967-72. 2002..CONCLUSION: These findings suggest that BM-derived EPCs make a significant contribution to angiogenic growth factor-induced neovascularization that may account for up to 26% of all ECs...
Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeabilityIoakim Spyridopoulos
Department of Cardiovascular Research, St Elizabeth s Medical Center, Boston, Mass 02135, USA
Arterioscler Thromb Vasc Biol 22:901-6. 2002..These results reveal that angiogenesis and vascular permeability induced by VEGF are mediated by mechanisms which ultimately diverge...
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemiaDouglas W Losordo
Division of Cardiology, Tufts School of Medicine St Elizabeth s Medical Center, Boston, Mass 02135, USA
Circulation 105:2012-8. 2002....
Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemiaRoberto Pola
Department of Medicine Cardiovascular Research, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Mass 02135 2997, USA
Circulation 108:479-85. 2003..Here, we studied whether the endogenous Hh pathway, in addition to its functions during embryogenesis, plays a physiological role in muscle regeneration after ischemia in adults...
All in the family: VEGF-B joins the ranks of proangiogenic cytokinesYoung-sup Yoon
Circ Res 93:87-90. 2003
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patientsF David Fortuin
Scripps Clinic, Green Hospital, La Jolla, California 92037, USA
Am J Cardiol 92:436-9. 2003..A randomized phase III trial is underway that will help determine the efficacy of vascular endothelial growth factor-2 gene transfer in "no-option" patients...
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarctionYoung Sup Yoon
Division of Cardiovascular Medicine, Caritas St Elizabeth s Medical Center, Boston, Massachusetts 02135, USA
J Clin Invest 115:326-38. 2005..To our knowledge, this is the first demonstration that a specific population of multipotent human BM-derived stem cells can induce both therapeutic neovascularization and endogenous and exogenous cardiomyogenesis...
Therapeutic myocardial angiogenesis with vascular endothelial growth factorsYoung Sup Yoon
Division of Cardiovascular Research, Caritas St Elizabeth s Medical Center, Boston, MA 02135, USA
Mol Cell Biochem 264:63-74. 2004....
Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemiaAtsuhiko Kawamoto
Division of Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 110:1398-405. 2004..CONCLUSIONS: Mobilization of endothelial progenitor cells with cytokines potentiates VEGF-2 gene therapy for myocardial ischemia and enhances bone marrow cell incorporation into ischemic myocardium...
Mending the broken heart: ischemic preconditioning-stimulated myocardial angiogenesisRaj Kishore
J Mol Cell Cardiol 37:1-3. 2004
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosisDirk H Walter
Department of Medicine, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 110:36-45. 2004..VEGF-2 gene-eluting stents may be considered as a stand-alone or combination therapy...
Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart diseaseAlberto Weber
Divisions of Cardiovascular Research and Cardiovascular Medicine, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
Eur J Cardiothorac Surg 26:137-43. 2004..CONCLUSIONS: Magnetically labeled EPCs transplanted for therapeutic neovascularization in myocardial ischemia can be visualized with ex vivo MRI at high-field strengths...
Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarctionYoung Sup Yoon
Division of Cardiovascular Medicine, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge St, Boston, Mass 02135, USA
Circulation 109:3154-7. 2004..Thus far, no significant deleterious effects or complications have been reported in any studies using BM-derived cells for treatment of various cardiac diseases...
Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapiesDouglas W Losordo
St Elizabeth's Medical Center, 736 Cambridge St, Boston, Mass 02135, USA
Circulation 109:2692-7. 2004
Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokinesDouglas W Losordo
St Elizabeth's Medical Center, 736 Cambridge St, Boston, Mass 02135, USA
Circulation 109:2487-91. 2004
Transplant graft vasculopathy: a dark side of bone marrow stem cells?Masaaki Ii
Division of Cardiovascular Research, Caritas St Elizabeth s Medical Center, University, School of Medicine, Boston, Mass 02135, USA
Circulation 108:3056-8. 2003
Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injuryAtsushi Iwakura
Division of Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 108:3115-21. 2003....
Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signal transduction pathwaysRaj Kishore
Division of Cardiovascular Research, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circ Res 93:932-40. 2003..Targeted inactivation of JNK1 at arterial injury sites may represent a potential therapeutic intervention for ameliorating TNF-mediated EC dysfunction...
Transplantation of endothelial progenitor cells for therapeutic neovascularizationAtsuhiko Kawamoto
Division of Cardiovascular Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, MA, USA
Cardiovasc Radiat Med 3:221-5. 2002..Further basic research, with improved understanding of the mechanisms governing homing and incorporation of EPCs, will be still necessary to optimize the methodology of the cell therapy...
Angiogenic gene therapy: pre-clinical studies and phase I clinical dataRiyaz Bashir
Tufts University School of Medicine, Boston, Massachusetts, USA
Kidney Int 61:S110-4. 2002..In general, these conditions are characterized by local hypovascularity, and the approach to treatment is therefore focused on stimulating neovascularization...
